Amgen stock edges higher to $330.51 as new data in rare autoimmune diseases presented, Amgen announces

Traders Union
All News
Companies
Amgen gains 0.68% to $330.51 today

Highlights

AMGN remains under short- and medium-term pressure, trading below key averages but finding some support above its long-term trend line.
Bearish momentum dominates as technical indicators signal weak trend strength, mild oversold readings, and persistent selling activity.
Expected price action for the coming week is confined to a $324–$337 range, with a low probability of a meaningful bullish reversal.

Bearish pressures hold as price hovers between key moving averages

AMGN is trading at $330.51, just below the MA-20 ($332.62) and well under the MA-50 ($341.06), but sits above the MA-200 ($328.62). This position signals ongoing short- and medium-term bearish pressure, while the MA-200 provides some long-term support. The Ichimoku Kijun is at $335.03, which stands as immediate resistance. Near-term support is found at the MA-200 ($328.62), with key support at the MA-100 ($350.24, but over 5% away and thus less actionable), while resistance clusters around the MA-20 ($332.62) and the Ichimoku Kijun ($335.03).

Momentum remains weak as sellers dominate despite mild oversold signals

AMGN shows weak momentum on D1, as the MACD issues a strong sell and ADX reads neutral at a low 12.61, suggesting trend indecision. RSI (41.16), Stoch RSI (28.14), and CCI (–82.78) all point to mild oversold territory, but none are deeply stretched. BBP at –4.04 confirms that sellers continue to dominate intraday flows despite some support from buyers on shorter timeframes. The Awesome Oscillator also signals “sell,” reinforcing a bearish undertone. Over the past week, AMGN has fallen $6.37 (1.83%) from a prev_week_close of $336.88, now positioned mid-range after rebounding from the week low. Weekly volatility stands at 4.07%, and the tone reflects a steady pullback after testing highs, with no strong signs of reversal.

Downside bias persists as sellers outweigh limited bullish scenarios

For the coming week, the expected range is $324–$337, keeping price action well within 10% of the current level and anchored above the 52-week low ($267.83) and below the 52-week high ($391.29). Based on W1 indicators—MA-50-w1 (“Buy”), while RSI-W1, ADX-W1, and MACD-W1 are neutral or sell—the probability of a price increase is very low (less than 20%), making further downside more likely. In the baseline scenario, AMGN will hold within the $324–$337 corridor as sellers and buyers reach an uneasy balance. A bullish break above $335 (immediate resistance) could open the way for a move toward $341, though indicators signal low odds for such a recovery. Alternatively, if price falls below $328 (MA-200), support could be tested near $324, with momentum favoring continued bearish bias.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Amgen was consolidating within a stable long-term trend despite near-term technical uncertainty. The current article builds on this outlook by examining whether recent shifts in momentum or news flow may prompt a decisive move, making it essential for traders to watch for confirmation of a new trend direction.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.